VPS35 and Alzheimer disease: Mutations in VPS35 and loss of its protein expression destabilize the retromer complex and promote endolysosomal dysfunction-pathological features commonly observed in AD, Parkinson’s disease, and other neurodegenerative disorders [28,29].